

CD19+ B cells are a type of white blood cell that plays a crucial role in the immune system. These cells are part of the adaptive immune response and are responsible for producing antibodies that help fight harmful pathogens. CD19+ is a protein marker found on the surface of most B cells, and measuring the levels of these cells gives valuable information about the body’s immune health. It is also an important marker for certain types of blood cancers, including leukemias that arise from B-lymphocytes and Burkitt’s lymphoma, helping doctors support the diagnosis and monitoring of these conditions as part of a panel.
The CD19 Count test uses a highly sensitive technique called flow cytometry to detect and count CD19+ B cells in a blood sample. It measures both the percentage of CD19 cells (%CD19 Cells) and the CD19 Absolute Count in the blood, which helps provide a detailed evaluation of B-cell status and immune function. This test is typically recommended when doctors suspect an immune disorder or a condition affecting B cells, such as leukemia or lymphoma. It may be advised if there are symptoms such as unexplained weight loss, pale skin, unusual bleeding, fever, night sweats, or swelling in the lymph nodes or organs. It also plays an important role in assessing how well a patient's immune system is recovering after bone marrow or organ transplantation, or in response to immunosuppressive therapy. Additionally, it also plays a vital role in monitoring disease recurrence, determining the extent of cancer involvement, and evaluating the effectiveness of treatment.
No special preparation is required for the CD19 Count test. However, provide a brief clinical history at the time of sample collection. Inform the doctor about all the medications, supplements, and underlying illnesses, as all these factors may affect the test results.
Test result ranges are approximate and may differ slightly between labs depending on the methodology and laboratory guidelines. Do not self-medicate and always consult a doctor to understand the test results correctly.
The CD19 Count test measures the number of CD19+ B cells in the blood. These cells play an important role in producing antibodies and fighting infections. It includes the CD19 Absolute Count, which indicates the actual number of CD19+ B cells present in the blood, and %CD19 Cells, which reflects the percentage of CD19+ B cells among total lymphocytes. Changes in CD19+ count can help identify how well the immune system is functioning and may be seen in conditions like immune suppression or certain blood cancers. This test is useful for evaluating immune-related disorders, monitoring disease progression, and guiding treatment decisions.
The CD19 Count test is done:
- To measure and monitor the level of B lymphocytes in the blood.
- To support the diagnosis and classification of the types of blood cancers like leukemia or lymphoma.
- To assess immune system function in immunodeficient patients.
- To monitor the effectiveness of therapies like chemotherapy or immunotherapy.
- To track immune recovery after organ or bone marrow transplant.
- To help in immunophenotyping of hematologic malignancies.
- Clinical history is preferred.

























